Patents by Inventor Guangyan LI

Guangyan LI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230087446
    Abstract: The embodiments of the present application provide a network monitoring method, an electronic device and a storage medium. The method includes: in response to receiving abnormal information reported by a network node, determining a suspicious region according to the abnormal information, the abnormal information is transmitted to the network management system from the network node in response to detecting by the network node that a network transmission index is abnormal; transmitting an acquisition instruction to the network node within the suspicious region, wherein the acquisition instruction includes an order for acquiring a device performance index of the network node; receiving the device performance index returned, in response to the acquisition instruction, by the network node within the suspicious region; and generating an abnormality analysis report according to the device performance index.
    Type: Application
    Filed: June 11, 2021
    Publication date: March 23, 2023
    Inventor: Guangyan Li
  • Patent number: 10799521
    Abstract: The present application relates to a method of icaritin in preventing or treating hematocytopenia. Particularly, icaritin may be used to prevent or treat bone marrow suppression caused by chemotherapeutic drugs, and may also be used to prevent or treat thrombocytopenia, for example, immune thrombocytopenia.
    Type: Grant
    Filed: December 23, 2019
    Date of Patent: October 13, 2020
    Assignee: LUNAN PHARMACEUTICAL GROUP CORPORATION
    Inventors: Zhiquan Zhao, Jingchun Yao, Xin Li, Yongxia Guan, Guangyan Li
  • Publication number: 20200147115
    Abstract: The present application relates to a method of icaritin in preventing or treating hematocytopenia. Particularly, icaritin may be used to prevent or treat bone marrow suppression caused by chemotherapeutic drugs, and may also be used to prevent or treat thrombocytopenia, for example, immune thrombocytopenia.
    Type: Application
    Filed: December 23, 2019
    Publication date: May 14, 2020
    Inventors: Zhiquan ZHAO, Jingchun YAO, Xin LI, Yongxia GUAN, Guangyan LI
  • Patent number: 10555962
    Abstract: The present application relates to use of icaritin in preparing a medicament for preventing or treating hematocytopenia. Particularly, icaritin may be used to prevent or treat bone marrow suppression caused by chemotherapeutic drugs, and may also be used to prevent or treat thrombocytopenia, for example, immune thrombocytopenia.
    Type: Grant
    Filed: October 20, 2014
    Date of Patent: February 11, 2020
    Assignee: Lunan Pharmaceutical Group Corporation
    Inventors: Zhiquan Zhao, Jingchun Yao, Xin Li, Yongxia Guan, Guangyan Li
  • Publication number: 20160250243
    Abstract: The present application relates to use of icaritin in preparing a medicament for preventing or treating hematocytopenia. Particularly, icaritin may be used to prevent or treat bone marrow suppression caused by chemotherapeutic drugs, and may also be used to prevent or treat thrombocytopenia, for example, immune thrombocytopenia.
    Type: Application
    Filed: October 20, 2014
    Publication date: September 1, 2016
    Applicant: Lunan Pharmaceutical Group Corporation
    Inventors: Zhiquan ZHAO, Jingchun YAO, Xin LI, Yongxia GUAN, Guangyan LI